3,464
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Effects of methylphenidate treatment in children with ADHD: a multimodal EEG/fNIRS approach

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 285-292 | Received 03 Aug 2018, Accepted 25 Oct 2018, Published online: 14 Nov 2018

References

  • Farone SV, Sergeant J, Gillberg C, et al. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry. 2003;2(2):104–113.
  • Biederman J. Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005;366:237–248.
  • Arnsten AF. Stimulants: therapeutic actions in ADHD. Neuropsychopharmacolog. 2006;31:2376–2383.
  • Spencer TJ. ADHD treatment across the life cycle. J Clin Psychiatry. 2004;65(Suppl 3):22–26.
  • Coghill D, Gagliano A, Pedroso S, et al. Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit/ hyperactivity disorder: evidence from a systematic review and a meta-analysis. Biol Psychiatry. 2014;76:603–615.
  • Yilmaz A, Gokcen C, Fettahoglu EC. et al. The effect of methylphenidate on executive functions in children with attention-deficit hyperactivity disorder. Bulletin of Clinical Psychopharmacology. 2013;23(2):162–170.
  • American psychiatric association diagnostic and statistical manual of mental disorders. 4th ed Washington (DC): American Psychiatric Association; 1994.
  • Skokauskas N, Hitoshi K, Shuji H, et al. Neuroimaging markers for the prediction of treatment response to methylphenidate in ADHD. Eur J Paediatr Neurol. 2013;17:543–551.
  • Rubia K, Alegria AA, Cubillo AI, et al. Effects of stimulants on brain function in attention-deficit/hyperactivity disorder: A systematic review and meta-analysis. Biol Psychiatry. 2014;76:616–628.
  • Durston S, Tottenham NT, Thomas KM, et al. Differential patterns of striatal activation in young children with and without ADHD. Biol Psychiatry. 2003;53:871–878.
  • Ehlis AC, Schneidera S, Dreslera T, et al. Application of functional near-infrared spectroscopy in psychiatry. NeuroImage. 2014;85(1):478–488.
  • Izzetoglu K, Bunce S, Onaral B, et al. Functional optical brain imaging using near-infrared during cognitive tasks. Int J Hum Comput Interact. 2004;17(2):211–227.
  • Moser SJ, Cutini S, Weber P, et al. Right prefrontal brain activation due to stroop interference is altered in attention-deficit hyperactivitydisorder – a functional near-infraredspectroscopystudy. Psychiatry Res Neuroim. 2009;173:190–119.
  • Monden Y, Dan H, Nagashima M, et al. Clinically-oriented monitoring of acute effects of methylphenidate on cerebral hemodynamics in ADHD children using fNIRS. Clin Neurophysiol. 2012;123:1147–1157.
  • Hermens DF, Cooper NJ, Kohn M, et al. Predicting stimulant medication response in ADHD: evidence from an integrated profile of neuropsychological, psychophysiological and clinical factors. J Integr Neurosci. 2005;4:107–121.
  • Ogrim G, Aasen IE, Brunner JF. Single-dose effects on the P3no-go ERP component predict clinical response to stimulants in pediatric ADHD. Clin Neurophysiol. 2016;127:3277–3287.
  • Polich J. Updating P300: an integrative theory of P3a and P3b. Clin Neurophysiol. 2007;118:2128–2148.
  • Sangal RB, Sangal JM. Attention-deficit/hyperactivity disorder: use of cognitive evoked potential (P300) to predict treatment response. Clin Neurophysiol. 2006;117:1996–2006.
  • Groom MJ, Scerif G, Liddle PF, et al. Effects of motivation and medication on electro-physiological markers of response inhibition in children with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2009;67:624–631.
  • Pliszka SR, Liotti M, Bailey BY, et al. Electrophysiological effects of stimulant treatment on inhibitory control in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2007;17:356–366.
  • Senderecka M, Grabowska A, Szewczyk J, et al. Response inhibition of children with ADHD in the stop-signal task: an event-related potential study. Int J Psychophysiol. 2012;85(1):93–105.
  • Savaşır I, ve Şahin N. Wechsler Çocuklar İçin zeka Ölçeği uygulama kitapçığı. Ankara: Türk Psikologlar Derneği; 1995.
  • Cope M, Delpy DT. System for long-term measurement of cerebral blood flow and tissue oxygenation on newborn infants by infrared transillumination. Med Biol Eng Comput. 1988;26:289–294.
  • Izzetoglu M, Izzetoglu K, Bunce S, et al. Functional near-infraredneuroimaging. IEEE Trans Neural Syst Rehabil Eng. 2005;13(2):153–159.
  • Fisch BJ. EEG PRIMER: basic principles of digital and analog EEG. 3rd ed. Richmond: Elsevier Academic Press; 1999.
  • Hoshi Y. Functional near-infrared optical imaging: utility and limitations in human brain mapping. Psychophysiology. 2003;40(4):511–520.
  • Ehlis AC, Bahne CG, Jacob CP, et al. Reduced lateral prefrontal activation in adult patients with attention-deficit/hyperactivity disorder (ADHD) during a working memory task: a functional near-infrared spectroscopy (fNIRS) study. J Psychiatr Res. 2008;42:1060–1067.
  • Monden Y, Dan H, Nagashima M, et al. Right prefrontal activation as a neuro-functional biomarker for monitoring acute effects of methylphenidate in ADHD children: An fNIRS study. Neuroimage Clin. 2012;1(1):131–140.
  • Davila CE, Srebro R. Subspace averaging of steady-state visual evoked potentials. IEEE Trans Biomed Eng. 2000;47(6):720–728.
  • Dereboy Ç, Şener Ş, Dereboy İF. Adaptation of Conners’ parent rating scale in Turkish study X. Ankara: Ulusal Psikoloji Kongresi; 1998.
  • Güven A, Altınkaynak M, Dolu N, et al. Effects of methylphenidate on reaction time in children with attention deficit / hyperactivity disorder. Arch Neuropsychiatry. (Article in Press). doi:10.29399/npa.22873.
  • Miller EK. Cohen JD. An integrative theory of prefrontal cortex function. Annu Rev Neurosci. 2001;24:167–202.
  • Bush G, Valera EM, Seidman LJ. Functional neuroimaging of attention-deficit/hyperactivity disorder: A review and suggested future directions. Biol Psychiatry. 2005;57:1273–1284.
  • Ardic UA, Ercan ES, Ercan E, et al. Osmotic release oral system methylphenidate is more effective than immediate release methylphenidate: A retrospective chart review in turkish children with attention deficit hyperactivity disorder. Bulletin of Clinical Psychopharmacology. 2014;24:342–349.
  • Rubia K, Halari R, Cubillo A, et al. Meth-ylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naive children with ADHD during a rewarded continuous performance task. Neuropharmacology. 2009;57:640–652.
  • Johnstone SJ, Barry RJ. Clarke AR ten years on: a follow-up review of ERP research in attention-deficit/hyperactivity disorder. Clin Neurophysiol. 2013;124:644–657.
  • Kratz O, Studer P, Malcherek S, et al. Attentional processes in children with ADHD: an event-related potential study using the attention network test. Int J Psychophysiol. 2011;81:82–90.
  • Lopez J, Lopez V, Rojas D, et al. Effect of psychostimulants on distinct attentional para-meters in attentional deficit/hyperactivity disorder. Biol Res. 2004;37(3):461–468.
  • Sawada M, Iida J, Ota T, et al. Effects of osmotic-release methylphenidate in attention-deficit/hyperactivity disorder as measured by event-related potentials. Psychiatry Clin Neurosci. 2010;64(5):491–498.
  • Liu S, Cai W, Liu S, et al. Multimodal neuroimaging computing: a review of the applications in neuropsychiatric disorders. Brain Inform. 2015;2:167–180.
  • Loo SK, Makeig S. Clinical utility of EEG in attention-deficit/hyperactivity disorder: a research update. Neurotherapeutics. 2012;9(3):569–587.
  • Monden Y, Dan I, Nagashima M, et al. Individual classification of ADHD children by right prefrontal hemodynamic responses during a go/no-go task as assessed by fNIRS. Neuroimage Clin. 2015;9:1–12.
  • Rapport MD, Denney C, DuPaul GJ, et al. Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children. J Am Acad Child Adolesc Psychiatry. 1994;33:882–893.